Delivery Order SPE2DB22D1017-SPE2DB25FF1SK

Award Date 12/19/24
Potential Completion Date 1/13/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the procurement of SPIKEVAX COVID-19 vaccine syringes. The contract has a firm fixed price of $7,158.90 and an ultimate completion date of December 6, 2024. The contract is classified as a delivery order and is not associated with any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $11,657.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of SPIKEVAX 2023-24 (12Y UP) syringes with a 0.5ML capacity, with a completion date of February 23, 2024. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,158.90, is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML syringes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 9, 2024. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,836.00, is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML syringes and has a completion date of January 2, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as...
This federal contract award, valued at $6,287.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SPIKEVAX 2024-25 (12Y UP) vaccine syringes. The contract has a completion date of September 23, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,418.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, a vaccine product, with a completion date of December 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $10,960.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of SPIKEVAX COVID-19 vaccine syringes. The award, valued at $2,794.28, is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that has a ceiling value of up to $999,999,999 through December 2025. The contract is for the supply of a wide range of medical commodities, including prescription...
This federal contract award, valued at $1,431.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, a medical product, with a completion date of May 5, 2025. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIKEVAX COVID-19 vaccine syringes (0.5 mL) for individuals aged 12 and up. The firm-fixed price delivery order, valued at $17,538.22, has an ultimate completion date of November 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF1SK
    Delivery Order

This federal contract award, valued at $7,090.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, a type of vaccine syringe, with a completion date of January 13, 2025.

The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 3/20/25, 10:51 AM